Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shang Yu Gong

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cell Reports|January 19, 2023
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccineAlexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2Jérémie Prévost, Jonathan Richard, Romain Gasser, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onsetSai Priya Anand, Jérémie Prévost, Manon Nayrac, et al.
Cell Reports. Medicine|May 10, 2021
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onsetSai Priya Anand, Jérémie Prévost, Manon Nayrac, et al.
Cell Reports|February 6, 2022
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infectionGuillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, et al.
Cell Reports|December 31, 2021
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimenManon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports|February 26, 2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between dosesDebashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cell Reports|January 19, 2023
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccineAlexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2Jérémie Prévost, Jonathan Richard, Romain Gasser, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onsetSai Priya Anand, Jérémie Prévost, Manon Nayrac, et al.
Cell Reports. Medicine|May 10, 2021
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onsetSai Priya Anand, Jérémie Prévost, Manon Nayrac, et al.
Cell Reports|February 6, 2022
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infectionGuillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, et al.
Cell Reports|December 31, 2021
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimenManon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports|February 26, 2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between dosesDebashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Pageof 3